Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond annotations that indicate read-only, open-world, and idempotent behavior, the description details that the tool makes a single parallel call, sorts results by primary metric, and returns paired data with citation URIs. It also explains how financial data is sourced (latest 10-K, handling off-calendar fiscal years), which is valuable context not captured by annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is dense but front-loaded with trigger phrases and examples. Every sentence contributes value, though it could be slightly more concise. The structure is logical: first trigger examples, then usage guidance, then data details.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given no output schema, the description adequately covers purpose, usage, behavioral details, parameter semantics, and result characteristics (sorted, citations). It explains data sources for both entity types and mentions sorting behavior. No additional information seems necessary for an agent to correctly invoke the tool.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% with descriptions for both parameters. The description enriches these by providing concrete examples (tickers/CIKs for company, drug names for drug) and clarifies that values array should contain 2-5 items. This adds meaningful context beyond the schema alone.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool's purpose: 'side-by-side comparison of 2–5 companies or drugs in ONE parallel call.' It uses specific verbs and provides example queries, effectively distinguishing it from sibling tools like entity_profile which likely do single-entity lookups.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly states 'ALWAYS PREFER over sequential single-pack lookups when comparing entities,' providing clear guidance on when to use this tool. It also explains the data sources for company and drug types, but does not explicitly state when not to use or mention alternatives beyond single lookups.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.3/5.0
Disambiguation2/5

Many tools have overlapping purposes, e.g., multiple ask_pipeworx variants and several Polymarket analysis tools. The presence of meta-tools like discover_tools and suggest_questions adds confusion. Distinguishing between tools like entity_profile, compare_entities, and recent_changes requires careful reading of descriptions.

Naming Consistency2/5

Naming conventions are mixed: some use snake_case (ai_visibility_check, ask_pipeworx), others use underscores (compare_entities, deep_research). Prefixes like pipeworx_ and polymarket_ are inconsistently applied, and there is no clear verb_noun pattern across the set.

Tool Count2/5

With 32 tools, the server is heavily over-scoped for its name 'Yc Rejection'. Only one tool directly relates to that domain. The rest constitute a full data platform, making the count far too high for the implied narrow purpose.

Completeness1/5

For a server named 'Yc Rejection', the tool set is severely incomplete: only one tool generates rejection text. There are no tools for application management, review, or related tasks. The actual completeness of the underlying platform is irrelevant given the misleading name.